Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-22 Pigot Timothy CHIEF COMMERCIAL OFFICER Grant or award · Stock Option (Right to Buy) +66,586 66,586
2024-01-22 Verwijs Marinus CHIEF TECHNOLOGY OFFICER Grant or award · Stock Option (Right to Buy) +66,586 66,586
2024-01-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option (Right to Buy) +66,586 66,586
2024-01-22 Gillies Hunter CHIEF MEDICAL OFFICER Grant or award · Stock Option (Right to Buy) +66,586 66,586
2024-01-22 Dake Benjamin T SEE REMARKS Grant or award · Stock Options (Right to Buy) +66,586 66,586
2024-01-22 Eldridge George A SEE REMARKS Grant or award · Stock Options (Right to Buy) +66,586 66,586
2024-01-17 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +4,000 $1.74 $7K 7,251
2024-01-17 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −4,000 $19.50 $78K 3,251
2024-01-17 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −4,000 6,027
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +1,400 $1.74 $2K 3,009
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +3,200 $2.14 $7K 6,209
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −2,126 $18.67 $40K 4,083
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −2,474 $19.57 $48K 1,609
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −900 14,208
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −500 9,588
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −500 11,394
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,200 36,108
2024-01-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,500 43,232
2024-01-02 Santel Donald J Director Grant or award · Stock Option (Right to Buy) +2,889 $13.49 $39K 2,889
2024-01-02 Dable Habib J Director Grant or award · Stock Option (Right to Buy) +2,964 $13.49 $40K 2,964

Page 9 of 16 · 315 trades